Synthesis, characterization, and anticancer evaluation of 1,3-bistetrahydrofuran-2yl-5-FU as a potential agent for pancreatic cancer

The failure of current chemotherapeutic agents for pancreatic cancer (PCa) makes it the most aggressive soft tissue tumor with a 5-year survival of slightly above 10% and is estimated to be the second leading cause of cancer death by 2030. Objective: The main aim was to synthesize, characterize and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ndemazie, Nkafu Bechem, Inkoom, Andriana, Ebesoh, Dexter, Bulusu, Raviteja, Frimpong, Esther, Trevino, Jose, Han, Bo, Zhu, Xue, Agyare, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773620/
https://www.ncbi.nlm.nih.gov/pubmed/36550419
http://dx.doi.org/10.1186/s12885-022-10449-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773620/
https://www.ncbi.nlm.nih.gov/pubmed/36550419
http://dx.doi.org/10.1186/s12885-022-10449-y

Ejemplares similares